140 related articles for article (PubMed ID: 1477641)
1. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
Koerner F; Boehnke M
Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
Zhao P; Wang W
Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
Schmitz K; Greite JH; Bartenschlager EM
Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
[TBL] [Abstract][Full Text] [Related]
4. [Acute band-shaped keratopathy after intraocular fibrinolysis with recombinant tissue plasminogen activator (rt-PA)].
Althaus C; Schelle C; Sundmacher R
Klin Monbl Augenheilkd; 1996 Nov; 209(5):318-21. PubMed ID: 9044983
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
Xie L; Li S; Dong X; Cao J; Shi W; Guo P
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):291-3. PubMed ID: 11877211
[TBL] [Abstract][Full Text] [Related]
7. [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].
Oficjalska-Młyńczak J; Marek J; Zajac-Pytrus H; Nizankowska MH; Koziorowska M
Klin Oczna; 1996; 98(6):423-5. PubMed ID: 9340414
[TBL] [Abstract][Full Text] [Related]
8. [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
Heiligenhaus A; Schilling H; Schilling M; Mellin KB
Ophthalmologe; 1996 Feb; 93(1):49-53. PubMed ID: 8867161
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of recombinant tissue plasminogen activator for anterior chamber fibrinolysis.
Lin CP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jun; 10(6):332-6. PubMed ID: 8057416
[TBL] [Abstract][Full Text] [Related]
10. Use of tissue plasminogen activator for intraocular fibrinolysis in dogs.
Gerding PA; Essex-Sorlie D; Vasaune S; Yack R
Am J Vet Res; 1992 Jun; 53(6):894-6. PubMed ID: 1626779
[TBL] [Abstract][Full Text] [Related]
11. Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis.
Wu TT; Wang HH
Eye (Lond); 2009 Jan; 23(1):101-7. PubMed ID: 17901882
[TBL] [Abstract][Full Text] [Related]
12. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
[TBL] [Abstract][Full Text] [Related]
13. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
Klais CM; Hattenbach LO; Steinkamp GW; Zubcov AA; Kohnen T
J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator and penetrating keratoplasty.
Heidemann DG; Williams GA; Blumenkranz MS
Ophthalmic Surg; 1990 May; 21(5):364-5. PubMed ID: 2116614
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of topically administered tissue plasminogen activator for intraocular fibrinolysis in dogs.
Gerding PA; Hamor RE; Ramsey DT; Vasaune S; Schaeffer DJ
Am J Vet Res; 1994 Oct; 55(10):1368-70. PubMed ID: 7998691
[TBL] [Abstract][Full Text] [Related]
16. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
Williams GA; Lambrou FH; Jaffe GA; Snyder RW; Green GD; Devenyi RG; Abrams GW
Arch Ophthalmol; 1988 Aug; 106(8):1055-8. PubMed ID: 3135790
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator for postvitrectomy fibrin formation.
Jaffe GJ; Abrams GW; Williams GA; Han DP
Ophthalmology; 1990 Feb; 97(2):184-9. PubMed ID: 2109297
[TBL] [Abstract][Full Text] [Related]
18. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
Zwaan J; Latimer WB
Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569
[TBL] [Abstract][Full Text] [Related]
19. Sonothrombolysis for intraocular fibrin formation in an animal model.
Yamashita T; Ohtsuka H; Arimura N; Sonoda S; Kato C; Ushimaru K; Hara N; Tachibana K; Sakamoto T
Ultrasound Med Biol; 2009 Nov; 35(11):1845-53. PubMed ID: 19699025
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy.
Hesse L; Chofflet J; Kroll P
Ger J Ophthalmol; 1995 Nov; 4(6):323-7. PubMed ID: 8751095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
